Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 1137-1142, March 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Altevogt, P.
Right arrow Articles by Apt, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Altevogt, P.
Right arrow Articles by Apt, D.

High-Frequency Generation of Altered Mr 70,000 env Glycoproteins in N-Methyl-N'-nitro-N-nitrosoguanidine-treated Murine Tumor Cells1

Peter Altevogt and Doris Apt

Institute for Immunology and Genetics, German Cancer Research Center, Im Neuenheimer Feld 280, D-6900 Heidelberg, Federal Republic of Germany

In previous studies we have characterized variant clones established following treatment of mouse Eb lymphoma cells with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Some of these clones were impaired in tumorigenicity due to an increased immunogenicity (tum- phenotype). In this paper we investigated the mutagenic effect of MNNG on cell surface molecules. The results show that retroviral Mr 70,000 glycoprotein (gp70) antigens undergo extensive alterations following MNNG treatment. In five of five mutant clones analyzed, the two-dimensional gel electrophoretic patterns of gp70 antigens were altered in comparison to the parental Eb cells. Peptide mapping analysis of immunoprecipitated gp70 molecules using three different enzymes revealed detectable changes in amino acid sequence in three of five mutant clones. In contrast, no alterations were detected in H-2Kd and H-2Dd antigens of the same clones. The gp70 antigens expressed by mutant clones could be resolved in three distinct clusters. Only one cluster induced antibodies in the syngeneic host. When genomic DNAs of MNNG clones were investigated by Southern blot analysis using a gp70-specific probe, an additional 4.5-kilobase hybridizing band could be detected that was not present in parental Eb cells and 5'-azacytidine-treated Eb clones. Collectively, our results show that gp70 antigens and genes are affected by MNNG treatment with high frequency. The possible role of structurally altered gp70 molecules in the immunogenicity of mutagenized tumor cells is discussed.

1 This work was supported by a grant from Deutsche Forschungsgemeinschaft (Al 170/3-2).

Received 7/ 7/87. Revised 10/ 6/87. Accepted 11/12/87.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.